Greenway Medical Technologies announced its participation in the Drug Information Association's (DIA) 45th annual convention taking place in San Diego.
During the DIA convention, Greenway, with its industry leading and 08 CCHIT Certified electronic heath record (EHR), PrimeSuite 2008, will be participating in the Clinical Data Interchange Standards Consortium’s (CDISC) live healthcare link demonstration. At the exhibit, Greenway will showcase its collaboration with the retrieve form for data capture’s (RFD) integration profile, which facilitates data interoperability between clinical research and clinical care providers by integrating the processes and workflows of electronic data capture (EDC), spontaneous adverse event (AE) reporting and EHRs such as PrimeSuite.
Currently, Greenway is the only leading EHR provider to fully embrace RFD in multiple real-world situations including several registry studies with Outcome Sciences and a multi-site retrospective study with Nextrials. Greenway also allows for the capabilities of the ASTER (Adverse Drug Event Spontaneous Triggered Electronic Reporting) study, which enhances pharmacovigilance whereby negative or adverse drug reactions can be reported instantly to the FDA, who can then report any issues or warnings to the public. Participation in demonstrations like those held at DIA help facilitate other real-world interoperability collaborations.
Greenway will be participating in two scenarios at DIA, a clinical research scenario and a drug safety scenario. Greenway’s PrimeSuite will highlight the source form within the EHR and allow for pre-population of the forms with relevant data that allows clinicians and care providers to review the data and complete any additional data entry prior to form submission.
“Our participation in the DIA show demonstrates the versatility and comprehensiveness of Greenway and its PrimeSuite solution,” said Jason Colquitt, director of research and outcomes at Greenway Medical. “It is important that the health IT industry continues taking the necessary steps that will lead to widespread interoperability and participation in shows such as DIA ensure that we are on the right path.”
“RFD has proven to be a very effective integration tool as it can sync an EHR such as Greenway’s PrimeSuite with multiple clinical research sponsors. The investigator can then easily surface their electronic case report forms from within the workflow of the EHR,” said Landon Bain of CDISC. “RFD also creates safeguards that enable the reporting of any adverse drug events as they happen.”